FDA shifts drug testing paradigm with plan to replace animal studies in monoclonal antibody development June 24, 2025July 9, 2025 Share More from the Blog A Regulatory Turning Point: A Recent Timeline of U.S. Actions to Reduce and Replace Animal Models in Preclinical Research Read More ChipChat™ Q&A: Modeling Complex Human Immune Response in the Colon Intestine-Chip Read More Recapitulating Inflammation: How to Use the Colon Intestine-Chip to Study Complex Mechanisms of IBD Read More Browse All